JPMorgan Chase & Co. Has Lowered Expectations for Procter & Gamble (NYSE:PG) Stock Price

Procter & Gamble (NYSE:PGGet Free Report) had its target price reduced by investment analysts at JPMorgan Chase & Co. from $165.00 to $157.00 in a research note issued on Thursday,Benzinga reports. The firm presently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s price target points to a potential upside of 7.85% from the company’s previous close.

Several other brokerages have also recently weighed in on PG. Wells Fargo & Company decreased their price target on Procter & Gamble from $173.00 to $170.00 and set an “overweight” rating on the stock in a research report on Thursday, September 25th. Berenberg Bank upped their target price on Procter & Gamble from $152.00 to $154.00 and gave the stock a “hold” rating in a research note on Wednesday, September 17th. Raymond James Financial cut their price objective on shares of Procter & Gamble from $185.00 to $175.00 and set an “outperform” rating for the company in a research note on Monday, October 20th. Jefferies Financial Group upgraded Procter & Gamble from a “hold” rating to a “buy” rating and lifted their price objective for the stock from $156.00 to $179.00 in a report on Tuesday. Finally, Dbs Bank raised shares of Procter & Gamble to a “hold” rating in a research note on Friday, December 5th. Thirteen equities research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $171.38.

Get Our Latest Stock Analysis on PG

Procter & Gamble Stock Performance

PG stock traded down $2.24 during midday trading on Thursday, hitting $145.57. The company’s stock had a trading volume of 3,686,854 shares, compared to its average volume of 8,211,846. Procter & Gamble has a 1 year low of $138.14 and a 1 year high of $179.99. The stock has a market cap of $340.16 billion, a price-to-earnings ratio of 21.29, a PEG ratio of 4.88 and a beta of 0.39. The stock’s 50-day moving average price is $147.53 and its 200 day moving average price is $153.78. The company has a quick ratio of 0.51, a current ratio of 0.71 and a debt-to-equity ratio of 0.46.

Procter & Gamble (NYSE:PGGet Free Report) last released its earnings results on Friday, October 24th. The company reported $1.99 earnings per share for the quarter, beating analysts’ consensus estimates of $1.90 by $0.09. Procter & Gamble had a net margin of 19.74% and a return on equity of 32.63%. The firm had revenue of $22.39 billion during the quarter, compared to the consensus estimate of $22.23 billion. During the same period in the prior year, the firm earned $1.93 EPS. The company’s revenue was up 3.0% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.100 EPS. On average, equities analysts forecast that Procter & Gamble will post 6.91 EPS for the current year.

Insider Activity at Procter & Gamble

In other news, CEO Jon R. Moeller sold 11,684 shares of the company’s stock in a transaction dated Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total transaction of $1,778,655.32. Following the completion of the sale, the chief executive officer owned 319,932 shares in the company, valued at approximately $48,703,248.36. This represents a 3.52% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, COO Shailesh Jejurikar sold 3,986 shares of the stock in a transaction dated Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total value of $606,788.78. Following the transaction, the chief operating officer directly owned 46,899 shares in the company, valued at approximately $7,139,434.77. This represents a 7.83% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 30,308 shares of company stock valued at $4,611,852. Insiders own 0.20% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of PG. MOKAN Wealth Management Inc. boosted its position in Procter & Gamble by 13.7% in the second quarter. MOKAN Wealth Management Inc. now owns 15,319 shares of the company’s stock valued at $2,442,000 after buying an additional 1,846 shares in the last quarter. Westerkirk Capital Inc. acquired a new position in shares of Procter & Gamble in the 2nd quarter worth approximately $4,796,000. Vega Investment Solutions grew its position in Procter & Gamble by 1.3% during the 2nd quarter. Vega Investment Solutions now owns 638,400 shares of the company’s stock worth $101,710,000 after acquiring an additional 8,500 shares during the last quarter. Caliber Wealth Management LLC KS increased its holdings in Procter & Gamble by 36.2% during the 2nd quarter. Caliber Wealth Management LLC KS now owns 17,798 shares of the company’s stock valued at $2,836,000 after purchasing an additional 4,730 shares in the last quarter. Finally, Jump Financial LLC bought a new position in Procter & Gamble in the 2nd quarter valued at $7,891,000. 65.77% of the stock is currently owned by institutional investors and hedge funds.

About Procter & Gamble

(Get Free Report)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

Read More

Analyst Recommendations for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.